My biggest concern. They have a lot of stuff in the cookie jar. When does someone really put their hand in and pay big bucks? Because once they do take a cookie, it can be years for them to develop it and the royalties to roll in. Or it may take years for us to develop something on our own.
Also, in the last two talks mark has talked about the big sales he has made in the past, over 4 years ago,
DuPont, shell, bdg, codesix(sp?) and how they have put 100’s of,millions into more R&D.
When do we ever see royalties from thos deals
Any thoughts?
Also, in the last two talks mark has talked about the big sales he has made in the past, over 4 years ago,
DuPont, shell, bdg, codesix(sp?) and how they have put 100’s of,millions into more R&D.
When do we ever see royalties from thos deals
Any thoughts?
Recent DYAI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 01:11:20 PM
- Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development • GlobeNewswire Inc. • 05/28/2026 11:25:00 AM
- Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 • GlobeNewswire Inc. • 05/21/2026 08:05:00 PM
- Sidoti Events, LLC's May Micro-Cap Virtual Conference • ACCESS Newswire • 05/20/2026 11:30:00 AM
- Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference • GlobeNewswire Inc. • 05/19/2026 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:11:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:10:46 PM
- Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 05/13/2026 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/12/2026 08:30:27 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/11/2026 08:42:09 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/01/2026 09:00:51 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2026 08:00:46 PM
- Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026 • GlobeNewswire Inc. • 04/29/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/28/2026 01:56:17 AM
- Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 03/25/2026 08:51:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:14:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:13:15 PM
- Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices • GlobeNewswire Inc. • 03/16/2026 11:20:00 AM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 • GlobeNewswire Inc. • 03/11/2026 08:10:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 10:04:30 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2026 10:02:34 PM
- Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free) • GlobeNewswire Inc. • 03/04/2026 12:20:00 PM
